MGC Pharmaceuticals' proprietary ZAM app "about good practice" | News Direct

MGC Pharmaceuticals' proprietary ZAM app "about good practice"

MGC Pharmaceuticals Ltd
News release by MGC Pharmaceuticals Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | March 27, 2023 03:00 AM Eastern Daylight Time

 

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM.

 

Clements explains why MGC is investing in medical technology, saying that "this is about good practice."

 

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com